Rates of vertebral bone loss before and after liver transplantation in women with primary biliary cirrhosis
Open accessThe DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
Atraumatic fractures caused by osteoporosis may be a serious complication of primary biliary cirrhosis. Mean (± S.D.) bone mineral density in the lumbar spine in 210 ambulatory women with primary biliary cirrhosis was 1.02 ± 0.19 gm/cm 2, 7% lower than that in 139 age-matched normal women (after adjustment for age and body weight) (p < 0.001). Bone mineral density in the lumbar spine was inversely related to a risk score index of liver disease severity (r = −0.29, p < 0.001). The mean rate of bone loss in 105 of these 210 women was 2%/yr ± 4%/yr, twice as great as in the 139 normal women (p < 0.02). In 20 women with primary biiary cirrhosis followed up after orthotopic liver transplantation, bone mineral density in the lumbar spine decreased at 3 mo (p < 0.01), and this decrease may have resulted in atraumatic fractures in 13 of them. Bone mineral density in the lumbar spine then increased (p < 0.01) so that by 12 mo the median bone mineral density in the lumbar spine was similar to that before transplantation and by 24 mo it was 5% above it. Therefore we conclude that the progressive bone loss observed in primary biliary cirrhosis (which is further accentuated immediately after transplantation) may be halted, and the bone mass may be restored toward normal within 2 to 3 yr after orthotopic liver transplantation. (HEPATOLOGY 1991;14:296-300.)
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Osteopenia may worsen for the first 6 months after transplantation, but bone mineral density returns to baseline after 12 months and improves thereafter.(254)”
From Primary Biliary Cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver Diseases (2019) · cites this paper as [254]
Citations
Cites
Regression Models and Life-Tables
Cox, D. R. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_37 · Cited by 26,297
Kaplan, M. M. (1987) · New England Journal of Medicine · doi:10.1056/nejm198702263160907 · Cited by 1,959
Applied Regression Analysis and Other Multivariable Methods.
Bhattacharyya, H. T., Kleinbaum, D. G., & Kupper, L. L. (1979) · Journal of the American Statistical Association · doi:10.2307/2287012 · Cited by 1,749
Riggs, B. L., Wahner, H. W., Dunn, W. L., Mazess, R. B., Offord, K. P., & Melton, L. J. (1981) · Journal of Clinical Investigation · doi:10.1172/jci110039 · Cited by 1,194
Self-citationPrognosis in primary biliary cirrhosis: Model for decision making
Dickson, R. E., Grambsch, P. M., Fleming, T. R., Fisher, L. D., & Langworthy, A. (1989) · Hepatology · doi:10.1002/hep.1840100102 · Cited by 816
Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis)
Ludwig, J., Dickson, E. R., & McDonald, G. S. A. (1978) · Virchows Archiv A Pathological Anatomy and Histology · doi:10.1007/bf00432479 · Cited by 753
Riggs, B. L., Wahner, H. W., Melton, L. J., Richelson, L. S., Judd, H. L., & Offord, K. P. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112462 · Cited by 510
Self-citationAHRENS, E. H., PAYNE, M. A., KUNKEL, H. G., EISENMENGER, W. J., & BLONDHEIM, S. H. (1950) · Medicine · doi:10.1097/00005792-195012000-00002 · Cited by 436
MOVSOWITZ, C., EPSTEIN, S., FALLON, M., ISMAIL, F., & THOMAS, S. (1988) · Endocrinology · doi:10.1210/endo-123-5-2571 · Cited by 404
Clinical Disorders of Bone and Mineral Metabolism
FRAME, B., & MAREL, G. M. (1983) · Annals of Internal Medicine · doi:10.7326/0003-4819-99-5-725 · Cited by 322
Research works printed but not linked: 5
- Cox, 1972, J R Stat Soc, Series B., 34, 248
- Atkinson, 1955, Q J Med, 99, 299
- Stellon, 1985, Q J Med, 57, 783
- Hodgson, 1987, Clin Res, 35, 861a
- Klaushofer, 1987, J Pharmacol Exp Ther, 243, 584
Cited by
Items 201–296 of 296
Low bone mineral density in noncholestatic liver cirrhosis: prevalence, severity and prediction
Figueiredo, F. A. F., Brandão, C. M. A., Perez, R. D. M., Barbosa, W. F., & Kondo, M. (2003) · Arquivos de Gastroenterologia · doi:10.1590/s0004-28032003000300004 · Cited by 9
Metabolic bone disease in patients with liver disease
Carey, E. J., & Balan, V. (2003) · Current Gastroenterology Reports · doi:10.1007/s11894-003-0012-z · Cited by 11
“Women with primary biliary cirrhosis have been shown to lose bone at a rate of 2% to 7% per year, which is significantly higher than the rate for healthy women of the same age [ 22 ,23].”
BackgroundInfluentialBone involvement in patients with chronic cholestasis
Gars, L. L. (2002) · Joint Bone Spine · doi:10.1016/s1297-319x(02)00413-x · Cited by 7
Osteoporosis in chronic liver disease
Heathcote, J. (1999) · Current Gastroenterology Reports · doi:10.1007/s11894-999-0001-y · Cited by 7
“Pre- and post‐liver transplantation studies by the same group and by another have shown that, in patient undergoing liver transplantation for cholestatic liver disease, improved bone metabolism is noted 3 to 6 months after transplantation [ 13 ,14].”
BackgroundIshibashi, H., Nakanuma, Y., Ueno, Y., Egawa, H., Koike, K., Komori, A., Sakisaka, S., Shimoda, S., Shirabe, K., Zeniya, M., et al. (2012) · Kanzo · doi:10.2957/kanzo.53.633 · Cited by 7
Javed, M., Arif, S., Khan, I. M., Hameed, K., Rehman, S., Khattak, A. K., Ahmad, I., & Khan, S. A. (2009) · PubMed · Cited by 13
Robson, S. C., Neuberger, J., & Williams, R. L. (1994) · Journal of Hepatology · doi:10.1016/s0168-8278(05)80321-6 · Cited by 6
Bone abnormalities in gastrointestinal and hepatic disease
Sylvester, F. A. (1999) · Current Opinion in Pediatrics · doi:10.1097/00008480-199910000-00006 · Cited by 6
Preventative care in cholestatic liver disease: Pearls for the specialist and subspecialist
Malik, A., Kardashian, A. A., Zakharia, K., Bowlus, C. L., & Tabibian, J. H. (2019) · Liver Research · doi:10.1016/j.livres.2019.04.001 · Cited by 8
Stein, E. M., Compston, J. E., & Shane, E. J. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-374602-3.00037-7 · Cited by 5
Hay, J. E. (1998) · Clinics in Liver Disease · doi:10.1016/s1089-3261(05)70015-5 · Cited by 6
High bone fracture risk in a large modern cohort of liver transplant recipients
Zavatta, G., Vitale, G., Morelli, M. C., Pianta, P., Turco, L., Cappa, F. M., Ravaioli, M., Cescon, M., Piscaglia, F., Altieri, P., et al. (2024) · Internal and Emergency Medicine · doi:10.1007/s11739-024-03767-5 · Cited by 5
Bone Disease after Liver Transplantation
Guañabens, N., & Monegal, A. (2005) · Elsevier eBooks · doi:10.1016/b978-012183502-6/50016-x · Cited by 5
Osteoporosis following organ transplantation: pathogenesis, diagnosis and management
Sakhaee, K. (2011) · Expert Review of Endocrinology & Metabolism · doi:10.1586/eem.10.86 · Cited by 5
Abate, E. G., VEGA, M. N. V., Rivas, A. M., Meek, S., Yang, L., Ball, C. T., & Kearns, A. E. (2020) · Endocrine Practice · doi:10.1016/j.eprac.2020.10.008 · Cited by 6
An Update on Bone Abnormalities Associated with Gastrointestinal and Liver Disease
Sylvester, F. A. (2001) · The Endocrinologist · doi:10.1097/00019616-200103000-00002 · Cited by 5
Clark, V., & Levy, C. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-118-5_3 · Cited by 5
Alex, G., Catto‐Smith, A. G., Ditchfield, M. R., Roseby, R., Robinson, P. J., Cameron, F. J., & Oliver, M. R. (2006) · Pediatric Pulmonology · doi:10.1002/ppul.20337 · Cited by 5
“Osteoporosis was identified in 13–35% of these groups.(21,22) Although some of these studies suggested that cholestasis itself is a risk factor for osteoporosis, this may just be a reflection of the coexistence of cirrhosis.”
BackgroundCohen, A., & Shane, E. J. (2001) · Current Opinion in Endocrinology & Diabetes · doi:10.1097/00060793-200112000-00004 · Cited by 5
Chiou, D., Mooney, B., Shi, B. Y., Upfill-Brown, A. M., Kallini, J. R., SooHoo, N. F., & Johnson, E. E. (2024) · Journal of Orthopaedic Trauma · doi:10.1097/bot.0000000000002788 · Cited by 4
Liver function linked to bone health: A bibliometric of the liver-bone axis
Zhang, W., Xu, X., Song, X., Zhang, Z.-R., Zhang, X.-R., Yang, B., Tao, Z., Zhang, Z., & Zhou, X. (2025) · World Journal of Hepatology · doi:10.4254/wjh.v17.i2.103016 · Cited by 5
Chalès, G., & Guggenbuhl, P. (2001) · Revue du Rhumatisme · doi:10.1016/s1169-8330(01)00171-5 · Cited by 4
Contreras-Omaña, R., Velasco, J. A. V.-R., Castro‐Narro, G., Trujillo-Benavides, O. E., Zamarripa-Dorsey, F., Dorantes, Á. A. R., Muñoz-Espinosa, L. E., Aiza-Haddad, I., Castillo-Barradas, M., Reyes, E. C., et al. (2021) · Revista de Gastroenterología de México (English Edition) · doi:10.1016/j.rgmxen.2021.04.003 · Cited by 6
Allocca, M., Crosignani, A. L., GRITTI, A., Benetti, A., Zuin, M. G., Podda, M., & Battezzati, P. M. (2006) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.03181.x · Cited by 4
Care of the Liver Transplant Patient
Kallwitz, E. R., & Cotler, S. J. (2008) · Disease-a-Month · doi:10.1016/j.disamonth.2008.03.003 · Cited by 4
Transplantation for Primary Biliary Cirrhosis
Imam, M. H., & Talwalkar, J. A. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-0268-8.00013-0 · Cited by 4
Epstein, S., & Shane, E. J. (2001) · Elsevier eBooks · doi:10.1016/b978-012470862-4/50053-2 · Cited by 5
Bone Abnormalities in Gastrointestinal and Hepatic Disease
Sylvester, F. A. (2001) · Reviews in Endocrine and Metabolic Disorders · doi:10.1023/a:1010059124994 · Cited by 4
Liver Transplantation: Indications
Neuberger, J. (2007) · Elsevier eBooks · doi:10.1016/b978-1-4160-3256-4.50123-x · Cited by 4
Liu, Y., & Stein, E. M. (2020) · Contemporary Endocrinology · doi:10.1007/978-3-319-69287-6_22 · Cited by 4
Gars, L. L., Grandpierre, C., Chazouillères, O., Berenbaum, F., & Poupon, R. (2002) · Revue du Rhumatisme · doi:10.1016/s1169-8330(01)00242-3 · Cited by 2
Late Complications of Liver Transplantation and Recurrence of Disease
Charlton, M., & Menon, K. V. (2005) · Elsevier eBooks · doi:10.1016/b978-0-7216-0118-2.50070-7 · Cited by 4
Post‐Transplantation Bone Disease: Prevalence, Monitoring, Prevention, and Management Guidelines
Dahir, K. M., Perry, B. C., & Jagasia, S. M. (2013) · Wiley eBooks · doi:10.1002/9781118473306.ch15 · Cited by 4
Rolling review: autoimmune liver disease
Mitchison, H. C., & Bassendine, M. F. (1993) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.1993.tb00075.x · Cited by 3
Sherlock, F. S., & BSc, J. D. (2001) · Wiley eBooks · doi:10.1002/9780470986820.ch14 · Cited by 3
A Prospective Open-Label Dose–Response Study to Correct Vitamin D Deficiency in Cirrhosis
Bowman, C. A., Bichoupan, K., Posner, S., Schonfeld, E. A., Pappas, A., Woodward, M., Schiano, T. D., & Branch, A. D. (2024) · Digestive Diseases and Sciences · doi:10.1007/s10620-023-08224-5 · Cited by 4
“…is a risk factor for increased morbidity among patients with chronic liver disease [5] and is prevalent in many conditions that co-occur with advanced liver disease, including metabolic syndrome [6], diabetes [7], cardiovascular disease [8], osteoporosis [9–13], and bone fractures [2, 14–18].”
Guggenbuhl, P., & Chalès, G. (2013) · Revue du Rhumatisme Monographies · doi:10.1016/j.monrhu.2013.02.002 · Cited by 2
Aspects nutritionnels des hépatopathies chroniques stables
Morgan, M. Y., & Madden, A. M. (1999) · Nutrition Clinique et Métabolisme · doi:10.1016/s0985-0562(99)80053-3 · Cited by 2
Enfermedad ósea postrasplante hepático
Guadalix Iglesias, S., Martínez Díaz-Guerra, G., & Hawkins Carranza, F. (2010) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 2
Shane, E. J. (2003) · Humana Press eBooks · doi:10.1007/978-1-59259-278-4_27 · Cited by 3
Vitamin D and Bone Mineral Metabolism in Hepatogastrointestinal Diseases
Bikle, D. D. (2011) · Elsevier eBooks · doi:10.1016/b978-0-12-381978-9.10069-1 · Cited by 6
Complications ostéoarticulaires des transplantations d'organe
Ayoub, G., & Bardin, T. (2007) · EMC - Appareil locomoteur · doi:10.1016/s0246-0521(07)41016-6 · Cited by 2
Bone disease after liver transplantation should not be underestimated.
Compston, J. E., & Alexander, G. (1997) · Gut · doi:10.1136/gut.40.5.695-b · Cited by 2
Clinical insights into the association between chronic liver disease and osteoporosis
Korkmaz, H. A., & Kahveci, A. (2026) · Osteoporosis International · doi:10.1007/s00198-026-08135-x · Cited by 2
“The literature indicates that up to 45% of children with VFs can be entirely asymptomatic at diagnosis, and this rate can reach approximately two-thirds in populations with broader chronic illness and glucocorticoid-induced osteoporosis [79].”
InfluentialOsteoporosis as a Complication of Transplant Medicine
Oleson, C. V., & Morina, A. B. (2017) · Springer eBooks · doi:10.1007/978-3-319-45084-1_15 · Cited by 1
Orlent, H., & Fevery, J. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00381-1 · Cited by 1
Osteoporosis in Gastrointestinal, Pancreatic, and Hepatic Diseases
Bikle, D. D. (2008) · Elsevier eBooks · doi:10.1016/b978-012370544-0.50051-3 · Cited by 3
Bone disease following liver transplant
Guadalix Iglesias, S., Martínez Díaz-Guerra, G., & Hawkins Carranza, F. (2010) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 3
Bone Disease Following Organ Transplantation
Gálvez-Treviño, R., Boltin, C., Pezeshk, P., & Chandraker, A. K. (2009) · Elsevier eBooks · doi:10.1016/b978-0-323-04177-5.00041-0 · Cited by 1
Bergasa, N. V. (2021) · Springer eBooks · doi:10.1007/978-1-4471-4715-2_8 · Cited by 1
Osteoporosis in organ transplant patients
Liu, Y., Krez, A. N., & Stein, E. M. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-813073-5.00052-6 · Cited by 2
Osteoporosis in Organ Transplant Patients
Stein, E. M., & Shane, E. J. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-415853-5.00056-x · Cited by 1
Management of primary biliary cirrhosis: osteoporosis
Parés, A. R. (1998) · Springer eBooks · doi:10.1007/978-94-011-4884-9_11 · Cited by 1
Post-Transplantation Osteoporosis: Prevention and Treatment
Suresh, U. (2001) · Graft · doi:10.1177/152216280100400410 · Cited by 1
Nonsteroid Immunosuppressive Agents and Bone
Epstein, S., & Inzerillo, A. M. (2004) · Clinical Reviews in Bone and Mineral Metabolism · doi:10.1385/bmm:2:2:091 · Cited by 1
“In these patients, fracture rates varies from 13 to 65%, with the highest rate found in patients with primary biliary cirrhosis ( 94 ,95).”
BackgroundOsteoporosis y trasplante de órganos sólidos
Guañabens, N. (2000) · Medicina Clínica · doi:10.1016/s0025-7753(00)71433-3 · Cited by 1
Intensive Care of the Intra-Abdominal Organ Transplant Recipient
Plevak, D. J., & Ruyter, M. L. D. (1998) · Seminars in Cardiothoracic and Vascular Anesthesia · doi:10.1177/108925329800200208 · Cited by 1
Bone Trauma 3: Stress Fractures
Peh, W., & Davies, A. M. (2005) · Springer eBooks · doi:10.1007/3-540-30000-7_16 · Cited by 1
Osteoporosis in Chronic Liver Disease
Ormarsdóttir, S. (2001) · Uppsala University Publications (Uppsala University) · Cited by 2
Chalès, G., & Guggenbuhl, P. (2003) · EMC - Hépatologie · doi:10.1016/s1155-1976(03)00075-5 · Cited by 1
Heathcote, E. J., & Milkiewicz, P. (2007) · Wiley eBooks · doi:10.1002/9780470691861.ch11a · Cited by 1
Stein, E. M., & Shane, E. J. (2009) · Humana Press eBooks · doi:10.1007/978-1-59745-459-9_26 · Cited by 1
Osteoporosi nel paziente sottoposto a trapianto d’organo
Giannini, S., Sella, S., & Carbonare, L. D. (2004) · L Endocrinologo · doi:10.1007/bf03344485
“Un progressivo recupero di mineralizzazione è stato descritto nei pazienti con precedente malattia epatica colestatica (4,18), mentre, nel suo complesso, la popolazione epato-trapiantata non sembra destinata a significativi incrementi di mineralizzazione scheletrica anche dopo molti mesi dal trapianto (20).”
BackgroundKaemmerer, D., & Lehm, G. (2012) · InTech eBooks · doi:10.5772/28168
Metabolic Bone Disease in Gastrointestinal Disorders
Cranney, A., Dube, C., Rostom, A., Tugwell, P., & Wells, G. A. (2004) · Wiley eBooks · doi:10.1002/9780470987025.ch14
DINAMIKA MINERAL'NOY PLOTNOSTI KOSTI U RETsIPIENTOV POSLE PERESADKI PEChENI
Ермакова, И. П., Moysyuk, Y. G., Бузулина, В. П., Колиашвили, Т. К., Yaroshenko, E. B., Корнилов, М. Н., Пронченко, И. А., & Shmerko, N. P. (2009) · Osteoporosis and Bone Diseases · doi:10.14341/osteo200922-4
Monegal, A., & Navasa, M. (2008) · Elsevier eBooks · doi:10.1016/b978-84-8086-310-0.50027-0
Taniai, N., Harihara, Y., Kita, Y., Akune, T., Tanaka, K., Hirata, M., Sano, K., Kusaka, K., Kubota, K., Takayama, T., et al. (2000) · Transplantation Proceedings · doi:10.1016/s0041-1345(00)01628-6
Os et corticoïdes Cinétique de perte osseuse et conséquences cliniques Prise en charge
Cormier, C. (1998) · Revue Française d Allergologie et d Immunologie Clinique · doi:10.1016/s0335-7457(98)80006-3
L’atteinte osseuse dans les maladies chroniques cholestatiques
Gars, L. L. (2002) · Revue du Rhumatisme · doi:10.1016/s1169-8330(02)00369-1
Complicaciones osteoarticulares de los trasplantes de órganos
Ayoub, G., & Bardin, T. (2008) · EMC - Aparato Locomotor · doi:10.1016/s1286-935x(08)70933-x
Foie, anticonvulsivants et métabolisme osseux
Devogelaer, J. (2000) · Revue du Rhumatisme · doi:10.1016/s1169-8330(00)80086-1
Gimeno, E. J., & Carranza, F. H. (2002) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/s0304-5412(02)70840-8
Kubo, A. (2000) · edoc Publication server (Humboldt University of Berlin) · doi:10.18452/14454
Osteoporosis y Metabolismo Mineral
Díez Pérez, A., Manteca, L. A., Izquierdo Delgado, E., Andrés Calvo, M., Vega Tejedor, G., Mendo González, M., Jl, P. C., Ivorra Cortés, J., Ivorra, R., Jj, A. S., et al. (2010)
Liver Transplantation for Primary Biliary Cirrhosis
Talwalkar, J. A., Kim, W. R., & Dickson, E. R. (2005) · Elsevier eBooks · doi:10.1016/b978-0-7216-0118-2.50017-3
Bone Disease in Chronic Cholestatic Liver Disease
Dobnig, H., & Fahrleitner, A. (2004) · Springer eBooks · doi:10.1007/978-1-4419-9034-1_22
Osteoporosis in Organ Transplant Patients
Furst, J. R., & Shane, E. J. (2016) · Springer eBooks · doi:10.1007/978-3-319-34238-2_11
Management of Bone Disease in Candidates for Organ Transplant
Ott, S. M. (2005) · Elsevier eBooks · doi:10.1016/b978-012183502-6/50023-7
Fracture Prevalence and Incidence in Solid Organ Transplant Recipients
Clarke, B. L., & Leidig‐Bruckner, G. (2005) · Elsevier eBooks · doi:10.1016/b978-012183502-6/50008-0 · Cited by 1
Prevalence of osteoporosis, osteopenia and vitamin d deficiency in cirrhotic patients
Atay, K., Hatemı, İ., Durcan, E., Eşkazan, T., Bozcan, S., Şahutoğlu, T., Canbakan, B., Özdemir, S., Tuncer, M. A., & Sonsuz, A. (2017) · Biomedical Research-tokyo · Cited by 2
Editorial Post-liver transplantation osteoporosis
Cheung, A. M. (2001)
Metabolic Bone Disease in Gastrointestinal Disorders
Cranney, A., Rostom, A., Dubé, C., Mohamed, R., Tugwell, P., Wells, G. A., & McDonald, J. W. (2010) · Wiley eBooks · doi:10.1002/9781444314403.ch16
Metabolic Bone Disease in Gastrointestinal Disorders
Bami, H., Lau, A. N., & Adachi, J. D. (2019) · Wiley eBooks · doi:10.1002/9781119211419.ch16
Elleuch, A., Chtourou, L., Chaabouni, K., Yaïch, K., Naifar, M., Fourati, H., Amouri, A., Baklouti, S., Tahri, N., & Ayadi, F. M. (2019) · Nutrition Clinique et Métabolisme · doi:10.1016/j.nupar.2019.10.002
Epstein, S. (2008) · Elsevier eBooks · doi:10.1016/b978-012370544-0.50055-0
Ku, M. Y., & Trotter, J. F. (2010) · Elsevier eBooks · doi:10.1016/b978-0-323-06397-5.00029-0
Deshmukh, S., Deshmukh, S., Parameswran, S. A., Pirmanayagam, P., Murgan, N., & Patil, S. R. (2021) · International Journal of Medical and Biomedical Studies · doi:10.32553/ijmbs.v5i4.1872
The Role of Parathyroid Hormone in the Evolution of Bone Loss after Organ Transplantation
Rubin, M. R., & Bilezikian, J. P. (2005) · Elsevier eBooks · doi:10.1016/b978-012183502-6/50010-9
Contreras-Omaña, R., Velasco, J. A. V.-R., Castro‐Narro, G., Trujillo-Benavides, O. E., Zamarripa-Dorsey, F., Dorantes, Á. A. R., Muñoz-Espinosa, L. E., Aiza-Haddad, I., Castillo-Barradas, M., Reyes, E. C., et al. (2021) · Revista de Gastroenterología de México · doi:10.1016/j.rgmx.2021.04.006 · Cited by 3
Sherlock, F. S., & BSc, J. D. (2001) · Wiley eBooks · doi:10.1002/9780470986820.ch13
Cholangitis and cholangiodysplasia
(2006) · Springer eBooks · doi:10.1007/3-540-28977-1_32
Kuntz, E., & Kuntz, H.-D. (2002) · Springer eBooks · doi:10.1007/978-3-662-04680-7_32
Impact of Liver Cirrhosis on Bone Metabolism
Abdalbary, M., Sobh, M., Abdelsalam, M., & El-Husseini, A. A. (2022) · Digestive Disease Interventions · doi:10.1055/s-0042-1743554
Steadman, C. J., Lynch, S. V., Kerlin, P., & Strong, R. W. (1992) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1992.tb137354.x
The metabolic bone disease of primary sclerosing cholangitis
Hay, E. J., Lindor, K. D., Wiesner, R. H., Dickson, R. E., Krom, R. A. F., & LaRusso, N. F. (1991) · Hepatology · doi:10.1002/hep.1840140209
“In patients with advanced disease and especially after liver transplantation, fractures caused by osteoporosis lead to considerable morbidity (7).”
BackgroundSelf-citation
Metadata
- Authors
- Eastell, R., Dickson, R. E., Hodgson, S. F., Wiesner, R. H., Porayko, M. K., Wahner, H. W., Cedel, S. L., Riggs, L. B., & Krom, R. A. F.
- Affiliations
- Mayo Clinic (US)
- Venue
- Hepatology
- Published
- 1991-08
- Volume
- 14
- Issue
- 2
- Pages
- 296-300
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W1982221537
- Cited by
- 297
- References
- 29
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 3 · 2023: 1 · 2022: 2 · 2021: 6 · 2020: 5 · 2019: 5 · 2018: 5 · 2017: 4 · 2016: 3 · 2015: 3 · 2014: 7 · 2013: 6 · 2012: 8
- FWCI
- 11.96
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- doi.wiley.com/10.1002/tdm_license_1.1 (tdm, 8797 d)
- Locations
- Hepatology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01am033230-02)
- Topics
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Keywords
- primary biliary cirrhosis, osteoporosis, bone mineral density, vertebral bone loss, liver transplantation, atraumatic fractures, lumbar spine, women, liver disease severity
- MeSH terms
- Female, Humans, Liver Cirrhosis, Biliary, Middle Aged, Osteoporosis, Postoperative Period, Spinal Diseases, Absorptiometry, Photon, Liver Transplantation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.